Generic drug of the therapeutic class: Analgesics
active ingredients: Atropine sulfate
- Atrioventricular or atrioventricular block.
- Pre-anesthesia: protection of vagal manifestations (bradycardia at induction).
- In myocardial infarction: prevention and treatment of atrioventricular blocks and sinus bradycardias.
- Treatment of Parkinson's syndrome (in Parkinsonism due to neuroleptics and as an adjuvant to levodopa in Parkinson's disease).
- Specific antidote in acute poisoning by anticholinesterase (organophosphorus insecticides and carbamates) or by parasympathicomimetic or cholinomimetic drugs.
- Spasmodic and painful digestive, vesicular and urinary manifestations.
Dosage ATROPINE SULFATE MERAM 0.25 mg / 1 ml Solution for injection Box of 100 ampoules of 1 ml
- Spasms :
. adult: 0.25 to 1 mg every 6 hours, in SC (maximum 5 mg / 24 h).
. children over 6 years: 0.5 mg as a single dose.
. child between 2 and 6 years old: 0.25 mg as a single dose.
- Pre-anesthetic medication : 1 mg SC.
- Atrioventricular block : 0.5 mg to 1 mg in IV.
- Antidote : 1 mg in IM, then same dose every 5 to 10 minutes, to obtain the dilation of the pupils, the stop of salivary secretion and perspiration.
Stopping the treatment too early may lead to lung edema and respiratory arrest.
- Risk of glaucoma by closing the angle.
- Paralytic ileus.
- Urethroprostatic disorders with risk of urinary retention.
- Breast-feeding: there is a passage in milk with atropine effects in children at therapeutic doses.
NOT RECOMMENDED :
Pregnancy: Prospective studies have not revealed human embryotoxicity or fetotoxicity in humans. Risk of atropine effect in children (ileus meconium).
Side effects Atropine Sulfate Meram
- Dry mouth.
- Thickening of bronchial secretions.
- Accommodation disorders, mydriasis, acute glaucoma.
- Urine retention, tachycardia, palpitations, constipation.
- Irritability, mental confusion in the elderly.